Over 20 Studies of InnoCare’s Orelabrutinib Presented at the 67th Annual Meeting of the ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
The American Journal of Managed Care

Study Identifies Key Predictors of Successful CD3+ Cell Apheresis for CAR T Manufacturing ...

The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...